Corcept Therapeutics
CORT
#3581
Rank
A$5.73 B
Marketcap
A$54.38
Share price
-2.70%
Change (1 day)
-34.45%
Change (1 year)

Market capitalization of Corcept Therapeutics (CORT)

Market cap: A$5.73 Billion

As of January 2026 Corcept Therapeutics has a market cap of A$5.73 Billion. This makes Corcept Therapeutics the world's 3581th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Corcept Therapeutics from 2004 to 2026

End of year Market Cap

Year Marketcap Change
2026A$5.73 B-55.93%
2025A$13.00 B47.11%
2024A$8.83 B79.85%
2023A$4.91 B52.95%
2022A$3.21 B1.9%
2021A$3.15 B-20.22%
2020A$3.95 B99.65%
2019A$1.97 B-9.25%
2018A$2.18 B-17.37%
2017A$2.64 B136.08%
2016A$1.11 B49.2%
2015A$0.74 B101.65%
2014A$0.37 B3.44%
2013A$0.35 B161.62%
2012A$0.13 B-51.11%
2011A$0.28 B2.11%
2010A$0.27 B42.31%
2009A$0.19 B168.74%
2008A$71.94 M-48.53%
2007A$0.13 B248.13%
2006A$40.15 M-64.45%
2005A$0.11 B-38.24%
2004A$0.18 B

End of Day market cap according to different sources

On Jan 12th, 2026 the market cap of Corcept Therapeutics was reported to be:

A$5.87 Billion
by Nasdaq info icon info icon
A$5.88 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
A$770.05 B 13,338.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$170.30 B 2,872.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$406.49 B 6,994.04%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
A$1.444 T 25,111.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$213.92 B 3,633.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$404.53 B 6,959.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
A$1.17 B-79.58%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
A$2.59 B-54.78%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$15.86 B 176.87%๐Ÿ‡บ๐Ÿ‡ธ USA